Profile of:

Gavin Clunie


Consultant Rheumatologist and Metabolic Bone Disease at Cambridge University Hospitals in UK.

Full name: Gavin Clunie

Current country: United Kingdom

Membership level: Full

Type of membership: Member

Number of publications: 10

Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults (2024)
https://pubmed.ncbi.nlm.nih.gov/39608805/

Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings (2024)
https://pubmed.ncbi.nlm.nih.gov/38391112/

Diagnostic and therapeutic practices in adult chronic nonbacterial osteomyelitis (CNO) (2023)
https://pubmed.ncbi.nlm.nih.gov/37480122/

A comparison of clinical examination and ultrasound enthesitis indices in patients with psoriatic arthritis, adjusted for concomitant fibromyalgia (2021)
https://pubmed.ncbi.nlm.nih.gov/33854573/

Loss and gain of bone in spondyloarthritis: what drives these opposing clinical features? (2020)
https://pubmed.ncbi.nlm.nih.gov/33240403/

Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/29077973/

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial (2015)
https://pubmed.ncbi.nlm.nih.gov/26135703/

An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis (2014)
https://pubmed.ncbi.nlm.nih.gov/24521738/

Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study (2014)
https://pubmed.ncbi.nlm.nih.gov/25125591/

‘Sink or swim’: an evaluation of the clinical characteristics of individuals with high bone mass (2012)
https://pubmed.ncbi.nlm.nih.gov/21455762/